Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State
- 12 November 2024
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 404-411
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Foundation (SCHWINQI0)
This publication has 23 references indexed in Scilit:
- Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypesPediatric Pulmonology, 2024
- Refinement of newborn screening for cystic fibrosis with next generation sequencingPediatric Pulmonology, 2022
- Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)Journal of Cystic Fibrosis, 2021
- Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screeningPediatric Pulmonology, 2020
- Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definitionJournal of Cystic Fibrosis, 2019
- Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, ItalyJournal of Cystic Fibrosis, 2019
- Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse PopulationHuman Mutation, 2015
- Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screeningJournal of Cystic Fibrosis, 2015
- Screening for cystic fibrosis in New York State: considerations for algorithm improvementsEuropean Journal of Pediatrics, 2015
- Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screeningPediatric Pulmonology, 2015